Parkinsonism in patients with chronic hepatitis C treated with interferon-α2b: a report of two cases

被引：8
|
作者：
Kajihara, Mikio [1 ]
Montagnese, Sara [1 ,3 ]
Khanna, Pooja [1 ]
Amodio, Piero [3 ]
Schapira, Anthony H. V. [2 ]
Dusheiko, Geoffrey M. [1 ]
Morgan, Marsha Y. [1 ]
机构：
[1] UCL, Ctr Hepatol, Dept Med, Sch Med, London NW3 2PF, England
[2] UCL, Univ Dept Clin Neurosci, Univ Coll London Med Sch, London NW3 2PF, England
[3] Univ Padua, Clin Med V, Dept Clin & Expt Med, I-35100 Padua, Italy
来源：
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY | 2010年 / 22卷 / 05期
关键词：
hepatitis C virus; interferon; Parkinsonism; DRUG-INDUCED PARKINSONISM; TUMOR-NECROSIS-FACTOR; ALPHA; THERAPY; PEGINTERFERON; PERSISTENT; RIBAVIRIN;
D O I：
10.1097/MEG.0b013e32833383e3
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Details of two patients with chronic hepatitis C infection who developed features of Parkinsonism when treated with IFN-alpha 2b and ribavirin are reported. The symptoms resolved when treatment was discontinued in one patient but not in the other. Physicians should be alert to the possibility that drug-related Parkinsonism may complicate treatment of hepatitis C infection with antiviral agents; the agent most likely responsible is IFN-alpha 2b. Prompt withdrawal of treatment is mandatory but does not always guarantee reversal of the Parkinsonian features. Eur J Gastroenterol Hepatol 22:628-631 (C) 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins.
引用
收藏
页码：628 / 631
页数：4
相关论文
共 50 条
  • [31] A prospective study of neuropsychiatric symptoms associated with interferon-α-2b and ribavirin therapy for patients with chronic hepatitis C
    Dieperink, E
    Ho, SB
    Thuras, P
    Willenbring, ML
    PSYCHOSOMATICS, 2003, 44 (02) : 104 - 112
  • [32] Interferon-α 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation:: A randomized study
    Samuel, D
    Bizollon, T
    Feray, C
    Roche, B
    Ahmed, SNS
    Lemonnier, C
    Cohard, M
    Reynes, M
    Chevallier, M
    Ducerf, C
    Baulieux, J
    Geffner, M
    Albrecht, JK
    Bismuth, H
    Trepo, C
    GASTROENTEROLOGY, 2003, 124 (03) : 642 - 650
  • [33] Interferon-α-2B and ribavirin in combination for chronic hepatitis C patients not responding to interferon-α alone:: An Italian multicenter, randomized, controlled, clinical study
    Barbaro, G
    Di Lorenzo, G
    Soldini, M
    Giancaspro, G
    Bellomo, G
    Belloni, G
    Grisorio, B
    Annese, M
    Bacca, D
    Francavilla, R
    Rizzo, G
    Barbarini, G
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 1998, 93 (12): : 2445 - 2451
  • [34] Interferon-α-2b Plus RibavirinA Review of its Use in the Management of Chronic Hepatitis C
    Lesley J. Scott
    Caroline M. Perry
    Drugs, 2002, 62 : 507 - 556
  • [35] Efficacy and safety of treatment with interferon-α2b plus ribavirin in children with chronic hepatitis C
    Iwona Mozer-Lisewska
    Nature Clinical Practice Gastroenterology & Hepatology, 2006, 3 : 316 - 317
  • [36] The development of hepatic granulomas following interferon-α2b therapy for chronic hepatitis C infection
    Ryan, BM
    McDonald, GSA
    Pilkington, R
    Kelleher, D
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 1998, 10 (04) : 349 - 351
  • [37] Interferon-α-2b plus ribavirin -: A review of its use in the management of chronic hepatitis C
    Scott, LJ
    Perry, CM
    DRUGS, 2002, 62 (03) : 507 - 556
  • [38] Benefit of interferon-α2b in a patient with unresectable hepatoma and chronic infection with hepatitis C virus
    Locker, GJ
    Mader, RM
    Steiner, B
    Wenzl, E
    Zielinski, CC
    Steger, GG
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2000, 12 (02) : 251 - 253
  • [39] Catatonia Associated with Pegylated Interferon-α 2b and Ribavirin for Hepatitis C
    Quinn, Davin
    Kuchler, Elizabeth
    Deming, Paulina
    Arora, Sanjeev
    PSYCHOSOMATICS, 2012, 53 (04) : 400 - 401
  • [40] Pegylated Interferon-α2a and Ribavirin versus Pegylated Interferon-α2b and Ribavirin in Chronic Hepatitis C A Meta-Analysis
    Flori, Nicolas
    Funakoshi, Natalie
    Duny, Yohan
    Valats, Jean-Christophe
    Bismuth, Michael
    Christophorou, Dimitri
    Daures, Jean-Pierre
    Blanc, Pierre
    DRUGS, 2013, 73 (03) : 263 - 277
12345